Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

FDA Keeps Avandia On The Market But Looks To RECORD For More Clarity On CV Risk

Sep 23 2010

• By The Pink Sheet Daily

Related Content

GSK Will End Avandia Promotion Worldwide

Sep 23 2010

EU Suspends Avandia; Pressure On Open Decision-Making May Stay

Sep 23 2010

Avandia Can Be Saved With New Warnings and REMS, Advisory Cmte. Says

Jul 14 2010

FDA Halts The TIDE Of New Avandia Patients; Informed Consent Changes Loom

Jul 21 2010

FDA's Marciniak vs. Unger: Cardio Experts Divided On GSK's RECORD Study

Jul 19 2010

IoM Report On Postmarketing Study Ethics Could Drive Broad Overhaul Of Informed Consent

Jul 09 2010

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window